<SEC-DOCUMENT>0001558370-20-000900.txt : 20200218
<SEC-HEADER>0001558370-20-000900.hdr.sgml : 20200218
<ACCEPTANCE-DATETIME>20200218160019
ACCESSION NUMBER:		0001558370-20-000900
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200218
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200218
DATE AS OF CHANGE:		20200218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Precipio, Inc.
		CENTRAL INDEX KEY:			0001043961
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				911789357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36439
		FILM NUMBER:		20625194

	BUSINESS ADDRESS:	
		STREET 1:		12325 EMMET ST
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
		BUSINESS PHONE:		203 787 7888

	MAIL ADDRESS:	
		STREET 1:		4 SCIENCE PARK
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRANSGENOMIC INC
		DATE OF NAME CHANGE:	20000119
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8-k.htm
<DESCRIPTION>8-K
<TEXT>
<!--HTML document created with Toppan Merrill Bridge  9.5.2.4-->
<!--Created on: 2/18/2020 2:00:10 PM-->
<html>
	<head>
		<title>
			PRPO - 8K- Regulation FD Disclosure - Feb 18, 2020
		</title>
	</head>
	<body><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<div><hr style="border-width:0;width:100%;height:1.5pt;color:gray;background-color:gray;" align="center"></div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">UNITED STATES</font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION<br></font><font style="display:inline;font-family:Times New Roman,Times,serif;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">WASHINGTON, D. C. 20549</font>
		</p>
		<div><hr style="border-width:0;width:20.59%;height:1.5pt;color:gray;background-color:gray;" align="center"></div>
		<p style="margin:0pt 0pt 6pt;text-align:center;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:10pt;">FORM 8-K </font>
		</p>
		<p style="margin:0pt 0pt 6pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:10pt;">CURRENT REPORT<br>PURSUANT TO SECTION 13 OR 15(d) OF THE<br>SECURITIES EXCHANGE ACT OF 1934 </font>
		</p>
		<p style="margin:5pt 0pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">Date of report (Date of earliest event reported): February 18, 2020</font>
		</p>
		<p style="margin:5pt 0pt;text-align:center;border-top:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:10pt;">PRECIPIO, INC.<br></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:10pt;">(Exact Name of Registrant as Specified in Its Charter)</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size:10pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:128.60pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:11.80pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:132.20pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:11.80pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:158.40pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:128.60pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:10pt;">Delaware<br></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:10pt;">(State of Incorporation)</font></p>
				</td>
				<td valign="top" style="width:11.80pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:132.20pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:10pt;">001-36439<br></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:10pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:10pt;">(Commission File Number)</font></p>
				</td>
				<td valign="top" style="width:11.80pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:158.40pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:10pt;">91-1789357<br></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:10pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:10pt;">(I.R.S. Employer Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">4 Science Park, New Haven, CT 06511</font>
		</p>
		<p style="margin:5pt 0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">(Address of principal executive offices) (Zip Code)</font>
		</p>
		<p style="margin:0pt 0pt 5pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;"> (203) 787-7888</font>
		</p>
		<p style="margin:5pt 0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">(Registrant's telephone number, including area code)</font>
		</p>
		<a name="page_de1292_1_2"></a><div><hr style="border-width:0;width:20.59%;height:1.5pt;color:gray;background-color:gray;" align="center"></div>
		<p style="margin:0pt 0pt 5pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">Not Applicable<br></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;">(Former name, former address and former fiscal year, if changed since last report date)</font>
		</p>
		<div><hr style="border-width:0;width:20.59%;height:1.5pt;color:gray;background-color:gray;" align="center"></div>
		<p style="margin:0pt 0pt 6pt;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </font>
		</p>
		<p style="margin:0pt 0pt 6pt 18pt;text-indent: -18pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&#x2610;<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </font>
		</p>
		<p style="margin:0pt 0pt 6pt 18pt;text-indent: -18pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&#x2610;<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </font>
		</p>
		<p style="margin:0pt 0pt 6pt 18pt;text-indent: -18pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&#x2610;<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </font>
		</p>
		<p style="margin:0pt 0pt 6pt 18pt;text-indent: -18pt;border-top:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&#x2610;<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;font-family:Wingdings;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:33.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;height:5.50pt">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:5.50pt;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:34.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;height:5.50pt">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:5.50pt;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:33.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;height:5.50pt">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;height:5.50pt;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="bottom" style="width:560.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Securities registered pursuant to Section 12(b) of the Act:</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:33.00%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;height:19.64pt">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Title of each class</font></p>
				</td>
				<td valign="bottom" style="width:34.00%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;height:19.64pt">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Ticker symbol(s)</font></p>
				</td>
				<td valign="bottom" style="width:33.00%;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;height:19.64pt">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Name of each exchange on which registered</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:184.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;height:13.35pt">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Common Stock, $0.01 par value per share</font></p>
				</td>
				<td valign="bottom" style="width:190.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;height:13.35pt">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">PRPO</font></p>
				</td>
				<td valign="bottom" style="width:184.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:1.5pt 1.5pt 1.5pt 1.5pt;height:13.35pt">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">The Nasdaq Stock Market LLC</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 23pt 0pt 0pt;line-height:111.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 23pt 6pt 0pt;line-height:111.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</font>
		</p>
		<p style="margin:0pt 0pt 6pt 0.35pt;line-height:10.35pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Emerging growth company </font><font style="display:inline;">&#x2610;</font>
		</p>
		<p style="margin:0pt 8pt 6pt 0.35pt;line-height:10.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </font><font style="display:inline;">&#x2610;</font>
		</p>
		<div><hr style="border-width:0;width:100%;height:1.5pt;color:gray;background-color:gray;" align="center"></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			&nbsp;
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"><p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt 0pt 6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">Item 7.01 <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font>Regulation FD Disclosure</font>
		</p>
		<p style="margin:6pt 0pt 0pt;background-color: #FFFFFF;text-indent:24.5pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;">On February 18, 2020 &nbsp;Precipio, Inc. (the &#x201C;</font><font style="display:inline;color:#000000;text-decoration:underline;">Company</font><font style="display:inline;color:#000000;">&#x201D;)&nbsp;&nbsp;issued a press release in connection with the advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership. &nbsp;The press release is furnished as Exhibit 99.1 and incorporated herein by reference.</font>
		</p>
		<p style="margin:6pt 0pt 0pt;background-color: #FFFFFF;text-indent:24.5pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#x201C;filed&#x201D; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#x201C;Exchange Act&#x201D;), or otherwise subject to the liabilities of that Section, nor shall it be deemed subject to the requirements of amended Item 10 of Regulation S-K, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information hereby shall not be deemed an admission as to the materiality of any such information.</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">Item 9.01 Financial Statements and Exhibits</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">(d) Exhibits</font>
		</p>
		<p style="margin:0pt;line-height:normal;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">99.1 &nbsp;<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font>&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;"><a href="ex-99d1.htm"><font style="font-family:Times New Roman,Times,serif;">Precipio Inc. Press Release February 18, 2020</font></a></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;"></font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"><p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:12pt 0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">SIGNATURE </font>
		</p>
		<p style="margin:12pt 0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:40.38%;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:13.62%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:46.00%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">PRECIPIO, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:40.38%;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:13.62%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:46.00%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:40.38%;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:13.62%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:06.56%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">By:</font></p>
				</td>
				<td valign="top" style="width:39.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">s/ Ilan&nbsp;Danieli&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:40.38%;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:13.62%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:06.56%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Name:</font></p>
				</td>
				<td valign="top" style="width:39.44%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Ilan&nbsp;Danieli</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:40.38%;padding:0pt 6.5pt">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:13.62%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:06.56%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Title:</font></p>
				</td>
				<td valign="top" style="width:39.44%;padding:0pt 2pt 0pt 2pt;">
					<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Chief Executive Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Date:<font style="display:inline;font-family:Times New Roman,Times,serif;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font>February 18, 2020 &nbsp;&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:avoid;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex-99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Toppan Merrill Bridge  9.5.2.4-->
<!--Created on: 2/18/2020 2:00:09 PM-->
<html>
	<head>
		<title>
			PRPO - 8K - 99.1 Poplar Partenrship
		</title>
	</head>
	<body><div style="margin-left:10.4575163398693%;margin-right:10.4575163398693%;"><div style="width:100%">

		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;text-align:right;color:#000000;font-family:Calibri;font-size: 11pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:10.4575163398693%;margin-right:10.4575163398693%;">
		<p style="margin:0pt 0pt 8pt;line-height:107.92%;text-align:center;font-family:Calibri;font-size: 8pt;">
			<a name="_gjdgxs"></a><font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;font-size:8pt;"><img src="ex-99d1g001.jpg" style="width: 3.825in; height: 0.7453358in" alt="image1.jpg"></font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:107.92%;text-align:center;color:#FF0000;font-family:Calibri;font-size: 14pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:14pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:107.92%;text-align:center;font-family:Calibri;font-size: 14pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;font-size:14pt;">Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;font-size:10pt;">NEW HAVEN, CT, (February 18, 2020) &#x2013; </font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">Specialty diagnostics company </font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#1155CC;font-size:10pt;text-decoration:underline;"><a href="#\h"><font style="font-family:Arial,Helvetica,sans-serif;color:#1155CC;font-size:10pt;text-decoration:underline;">Precipio, Inc.</font></a></font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;"> &nbsp;(</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#1155CC;font-size:10pt;text-decoration:underline;">NASDAQ: PRPO</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">), announced today that it is in advanced discussions with </font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#1155CC;font-size:10pt;text-decoration:underline;"><a href="#\h"><font style="font-family:Arial,Helvetica,sans-serif;color:#1155CC;font-size:10pt;text-decoration:underline;">Poplar Healthcare</font></a></font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">&nbsp;to establish&nbsp;a&nbsp;strategic partnership that includes, among other transactions, the acquisition of the customer base of Poplar&#x2019;s Hematopathology division, </font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#0000FF;font-size:10pt;text-decoration:underline;"><a href="#\h"><font style="font-family:Arial,Helvetica,sans-serif;color:#0000FF;font-size:10pt;text-decoration:underline;">OncoMetrix</font></a></font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">The planned transaction contemplates that Precipio will assume responsibility for OncoMetrix's customer base and associated revenues of approximately $3M (as of YE 2019, unaudited). This will represent a potential doubling of Precipio&#x2019;s&nbsp;current pathology services revenue, and should provide a substantial improvement to Precipio's laboratory economies of scale, resulting in increased gross margins. Assuming discussions proceed on course, Precipio anticipates this transaction to be completed in the next 90 days.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">As part of the transaction, three sales representatives of OncoMetrix will transition to Precipio. There is no consideration &#x2013; either cash or stock - to be exchanged between the parties at the outset. Each party expects to realize economic and cash benefits following the completion of the transaction. The impact&nbsp;to Precipio is essentially equivalent to the hiring of three experienced sales rep that immediately bring in a substantial book of business.&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">Additional elements of the transaction contemplated include Precipio offering Poplar&#x2019;s solid tissue pathology services, and Poplar offering Precipio&#x2019;s&nbsp;Hematopathology services, through their sales teams. As both companies have been engaged for several years in the pathology services business, each has developed various competencies and strengths in areas such as billing and contracting, laboratory technologies, logistics, sales and marketing. Both companies will share best practices, as well as leverage each other&#x2019;s&#x2019; relative advantages in the various areas, for the combined benefit of each company.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">Precipio&#x2019;s management is disclosing the potential transaction in order to ensure that no parties involved, including employees and providers for either company, would have advanced knowledge and or access to what could potentially be material non-public information. As contemplated, the transaction would likely represent a significant increase to Precipio&#x2019;s existing pathology business, internal economies of scale and geographic presence.</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">Both parties are currently in the process of negotiating definitive agreements&nbsp;to ensure that providers and their patients experience an orderly transition.&nbsp;However, there can be no assurances that any transaction will result from these negotiations, or of the terms, timing or approval of any such transaction. Precipio will provide further information once a definitive agreement has been reached, or if Precipio determines that further disclosure is warranted. While Precipio&#x2019;s management currently believes there is a high likelihood of completing this transaction in the next 90 days, investors should make their own assessment as to the impact of this announcement prior to the completion of the transaction.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">&#x201C;This strategic initiative represents a rapid and effective way to scale up our business without any dilution to our shareholders&#x201D;, said Ilan Danieli, Precipio CEO. &#x201C;Should this transaction take place, it will represent the successful execution of one of the strategic initiatives mentioned earlier this year, intended to grow our business and generate value to our shareholders.&#x201D;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:107.92%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;font-size:10pt;">About Precipio</font>
		</p>
		<p style="margin:12pt 0pt 8pt;background-color: #FFFFFF;line-height:105.83%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions </font></p></div><div style="margin-left:10.4575163398693%;margin-right:10.4575163398693%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;color:#000000;font-family:Calibri;font-size: 11pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:10.4575163398693%;margin-right:10.4575163398693%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:10.4575163398693%;margin-right:10.4575163398693%;"><div style="width:100%">

		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;text-align:right;color:#000000;font-family:Calibri;font-size: 11pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:10.4575163398693%;margin-right:10.4575163398693%;"><p style="margin:12pt 0pt 8pt;background-color: #FFFFFF;line-height:105.83%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;"><font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine, Harvard&#x2019;s Dana-Farber Cancer Institute and the University of Pennsylvania, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information, please visit</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#1155CC;font-size:10pt;">&nbsp;</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#1155CC;font-size:10pt;text-decoration:underline;">www.precipiodx.com</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:107.92%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;font-size:10pt;">Forward-Looking Statements</font>
		</p>
		<p style="margin:12pt 0pt 8pt;background-color: #FFFFFF;line-height:105%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<a name="_1fob9te"></a><font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">Certain statements in this press release constitute &#x201C;forward-looking statements,&#x201D; within the meaning of federal securities laws, including statements related to ICP technology, including financial projections related thereto and potential market opportunity, plans and prospects and other statements containing the words &#x201C;anticipate,&#x201D; &#x201C;intend,&#x201D; &#x201C;may,&#x201D; &#x201C;plan,&#x201D; &#x201C;predict,&#x201D; &#x201C;will,&#x201D; &#x201C;would,&#x201D; &#x201C;could,&#x201D; &#x201C;should,&#x201D; and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The Company&#x2019;s actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the known risks, uncertainties and other factors described in the Company&#x2019;s definitive proxy statement filed on May 29, 2018, the Company&#x2019;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 and on the Annual Report on Form 10-K for the year ended December 31, 2018 as well as the Company&#x2019;s prior filings and from time to time in the Company&#x2019;s subsequent filings with the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to in such statements. All information in this press release is as of the date of the release and the Company does not undertake any duty to update this information, including any forward-looking statements, unless required by law.</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:107.92%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;font-size:10pt;">Inquiries:</font>
		</p>
		<p style="margin:0pt 0pt 8pt;line-height:107.92%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;color:#1155CC;font-size:10pt;text-decoration:underline;">investors@precipiodx.com</font>
		</p>
		<p style="margin:12pt 0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;color:#222222;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#222222;font-size:10pt;">+1-203-787-7888 Ext. 523</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:10pt;">&nbsp;</font>
		</p></div><div style="margin-left:10.4575163398693%;margin-right:10.4575163398693%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;color:#000000;font-family:Calibri;font-size: 11pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:10.4575163398693%;margin-right:10.4575163398693%;page-break-after:avoid;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex-99d1g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex-99d1g001.jpg
M_]C_X  02D9)1@ ! @$       #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "D TH# 2(  A$! Q$!_\0
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MZUG-4TO=8*_4[$5A>(_$^G^%=/2[U R$.^Q(XERSGV'%;M>4_&W_ )!VD_\
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M%F]I>1AXVZ'NI]0>QK:G6<='L<U7#QGJMSP.NR\%^+6TN=-.O9,V4APC,?\
M5'_XFL+7M"N=!U!K:;YHV^:*4#AU_H:RJZVE4B<$7*E(^BP01D4M<'\/_$9O
MK;^RKI\SVZYB8GEH_3ZC^5=Y7!*+B[,]6$U.-T+1114EA1110 4444 %%%%
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M^U>M>&O$]OKMOM.([M!^\BS^H]17?0Q"GI+<]7"XI5%RRW.CHHHKJ.X****
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M?!^D^*+;49-269C Z!/+DV]0<_RK>G"')S2(;=[(W_\ A=T'_0"D_P# D?\
MQ-'_  NZ#_H!2?\ @2/_ (FMW_A47A?_ )YW?_?\T?\ "HO"_P#SSN_^_P":
M+T>P>\87_"[H/^@%)_X$C_XFD_X7A!_T I/_  )'_P 36]_PJ+PO_P \[O\
M[_FC_A47A?\ YYW?_?\ -%Z/8/>,'_A=\/\ T Y/_ D?_$U5O/C7<-$5L=%C
MC?'#S3EP/P '\ZZC_A47A?\ YYW?_?\ -26GPN\)1L)!9O/C^_<,1G\#3YJ/
M8/>/'KJ^\2>.]52-C/>S9^2*,8CC'TZ+]37K_@7P'#X6A^UW12;5)5PS@?+$
M/[J_U-=;8Z;8Z;!Y-C:0VT7]V) H/Y5<J)UN966B&HBT445D4>%?&?\ Y&VS
M_P"O)?\ T-Z]4\#?\B/HW_7JE>5_&?\ Y&VT_P"O)?\ T-Z]4\#_ /(CZ-_U
MZI714_A1(7Q,X_7/B]%I6LW5A;Z2URMO(8VE:X\O+#@X&T\9JC_PO$_]"\/_
M  ,_^PKL]2^'OAK6+Z2^N[$_:)3EVCE9-Q]2 <9JK_PJCPE_SY3?^!#_ .-2
MG3MJA^\<K_PO$_\ 0OC_ ,#?_L*7_A>)_P"A?'_@9_\ 85U/_"J/"7_/E-_X
M$/\ XT?\*H\)?\^4W_@0_P#C3YJ/87O'*_\ "\#_ -"^/_ W_P"PIT7QM0RJ
M)=!*QD_,RW>X@?38,UU'_"J/"7_/E-_X$/\ XT1?"WPG%,DG]GN^TYVO.Y!^
MHS1S4NP6D=?!,ES;Q3QG,<BAU)]",BIZ8JA5"J  . !VI]8%A1110!R_Q D,
M7@35V!P3#M_ L!_6O-O@M$&\2W\IZI:8'XNO^%>F^.X#<>"-811R+<O_ -\_
M-_2O+_@Q<+'XJO(">9;0D?@R_P")K>'\.1#^(]THHHK L**** "BBB@ HHHH
M **** $KRKXV_P#(-TG_ *[2?R%>JUY5\;?^0;I/_7:3^0K2E\:%+8UO@]_R
M)#?]?<G\EKOZX#X/?\B0W_7W)_):[^HJ?&P6QPWC#XB6?A34([ V4EU<,@D8
M*X0*#G'.#SP:Y_\ X7?!_P! *3_P)'_Q-<W\71CQR?>UC_K77>'_ (9>'-2\
M.Z;?7$=R9KBVCE<K,0-Q4$]JW4:<8)R)N[Z%;_A=T'_0"D_\"1_\32?\+P@_
MZ 4G_@2/_B:WO^%1>%_^>=W_ -_S1_PJ+PO_ ,\[O_O^:5Z/8/>,+_A=T'_0
M"D_\"1_\31_PNZ#_ * 4G_@2/_B:W?\ A47A?_GG=_\ ?\T?\*C\+_\ /.[_
M ._YHO1[#]XP?^%WP?\ 0"D_\"1_\36-J_QDU>\B:+3;.&P!X\PMYKCZ9 'Z
M&NW_ .%1^%O^>5T?^VYJ_8?#OPMISK)'I4<KCHUPQD_1CC]*.:DM4A6D>-:!
MX3UWQIJ)N7,OD.V9KZXR0?IG[Q]A^E>]Z%H5EX>TJ+3[&/;$G+,?O.W=B?6M
M)$6- B*%4# 4# %2=*SJ57/T*2L+1114#/FOQY_R4+5?^O@?R%?20^[7S;X\
M_P"2A:K_ -? _D*^DA]VMJWPQ(CNS"\9R&+P9K+CK]DD'YC%>2_!N(2>,IW(
MYCLW8?\ ?2#^M>N^+8#<^$M7B49+6DF/J%)KQ[X/W"P^-C&3_KK5T'U!#?T-
M53_AR![H]]HHHKG+"BBB@ HHHH **** "BBB@#Q7XV1 :OI4H'S- ZD^P;_[
M(UP,>M20Q)%YA^10O7TKNOC5<!M?TZW'6.V+G_@3'_XFN;M/!\ES9P7 4XEC
M5^GJ,UZ%&W(KF4MSZ2HHHKSS4**** "BBB@ HHHH 2LO4M"T[55(NK2.1L8W
MXPP_$<UJTVDTGHQ.*DK,\[U/X;L,OIMUD?\ /*?_ .*'^%<G-8ZMH%VDTD,U
MO)&V4D XS['H?I7N%12Q1S(5D165N"",@US3PT7K'1G'4P<&[PT9SGACQ7#K
M40AFVQ7B#YD[-[K_ (5T_.VN8OO!6G33BYLR]C<J=RO > ?]W_#%;=A'>);B
M.]9'E7CS4X#^^.QK6GS+21O2YTN67WE^BBBM38**** .$^)<M];Z'!/9W4T*
M"79,L;;=P8<9(^GZUX\3DY)_&O=_'4 N?!VHJ1RJ"0?\!8'^E>$5Z.#:<#GJ
M[A111789'I?PDNR)=2LR>H251^8/]*]0KQOX6RE/%,J9^_;,/U4U[(:\G%*U
M1G33?NBT445@:&?K8SH.HC_IVD_]!->#?"O_ )*#I_\ N2_^BVKWO6?^0'J'
M_7M)_P"@FO!/A7_R4'3_ /<E_P#1;5M3^"1#W1]$T445B6%%%% !1110 444
M4 %%%% 'G_QA_P"1)7_K[C_DU8_P1_X\M8_ZZ1?R:MCXP?\ (DC_ *^H_P"3
M5C_!'_CRUG_KI%_)JV7\)D?:/6****Q+"BBB@#%\46=W>^&-1M;"0I=20,(R
M#@D^F??I^->+?#7Q,^@>)!8W3LMG>,(I%8\1R?PM[<\'Z^U?0=>"_%;PP=(U
MT:K;1XM;YBS8'"2]_P ^OYUM1:=X/J3+N>\TM<9\._$W_"1>&T$S[KVTQ%/D
M\MQ\K?B!^8-=E64DXNS&G<6BBBD,\+^,_P#R-EI_UY+_ .AO7J?@;_D1M&_Z
M]4KRSXT?\C;9_P#7DO\ Z&]>I^!O^1&T;_KU2NB?\.)"W.AHHHKG+"BBB@ H
MHHH **** "BBB@"K>6R7ME/:R?<FC:-OH1@U\Z>%+Q_"_C^U-R=GD7+6\^>P
M.4.?IU_"OI6O!_BWX>;3O$*ZM"G^CWP^8CHLHZ_F,'\ZVH/5Q?4F7<]W%+7%
M_#KQ,OB+P[&DKYOK,"*8'JP_A?\ $#\P:[,5E).+LQH6BBBD,**** "BBB@
MHHHH 2O*OC;_ ,@W2?\ KM)_(5ZK7E7QM_Y!ND_]=I/Y"KI?&A2V-;X/?\B0
MW_7W)_):[^N ^#W_ ")#?]?<G\EKOZ4_C8+8\#^,'_([_P#;K'_-J]A\'?\
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M%:4OC0I;&M\'O^1(;_K[D_DM=_7 ?![_ )$IO^ON3^2UW]34^-@MCP3XP_\
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M]UUYCF7^1'^>*WTK+S(UB?2]+7G'AKXK:5JJI!JI&GW70LQ_=-]&_A_'\Z]
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M[VW_ 'X%)_PMKQ7_ ,_%M_WX%>X_\(_HO_0(L/\ P&3_  H_X1_1?^@18?\
M@,G^%/VD/Y0L^YX?_P +;\5_\][;_OP*/^%M^*_^>]M_WX%>X?\ "/Z+_P!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SWXD>"CX@T_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@!*C=UC0N[!549))P!4E<6\;^,=5N$ED==#LY#%Y:,1]JD'7)'\(II7W
M$V:$_CG0()3$+TS..OD1-(/S Q3/^$]T/^_=?^ K_P"%;UK9VUE"(;6".&(=
M%C4 59Q1>/8-3.N-5L[33TU">4QVSA,,4.?FP!QC(ZBM&L;Q/IIU7PY>VD7^
MM=-T?^\IW#]12^'=736M(BN1Q*!LFC/5)!U!%%M+H+ZV-FBBJ]Q<0VEO)<3N
ML<4:EG9CP *0R&#4+>XOKJSB?=/:[/.3!^7<,CGOQ61<>--$M+B6WEN)A+$Y
M1@+>0X(//..:C\(1RW2ZAK4R,AU*??&K=?*4;4S^%=/3=D[,6K1S/_">Z!_S
M\S_^ TG^%7M+\3:1K$ACLKQ7E')B92C?DP!K9Q7*>-;"%M(EU2/$-_8@30SJ
M,,"#T)[@],4U9NPM4;>J:K::/9&[O)#'"&"Y"ECD].!63_PGF@?\_$__ ("R
M?_$U!XMF-QX7L9V7:9+FV<KZ98&NK HT2NPUN<W_ ,)YH'_/Q/\ ^ LG_P 3
M4UCXPTC4+R.TMYIFFD.%!MW4?F17045-X]AZA6;J6LZ;I$>^_O(H >@9OF/T
M Y-5O$>K/I-@IMXQ+>W$@AMHS_$YZ9]AUJOHWABWLC]LOR+[4I/FEN9ANP?1
M0?N@4U%6NPOT1'_PGV@?PW$[#L1;2<_^.U9T[Q;I.JWBVEI+,\S D!H'4<#/
M4BM[ HH;C;1!J8>I^*=+TFZ^S7DLJ2[0V%A=A@^X%5?^$]T#_GXG_P# :3_"
MNEQ[T$9H375!J<NOC_P\P)6YF/;BVD_PIW_">:!_S\3_ /@-)_A2^"/^01=_
M]?T__H5=+3ER)VM^(E=HCCD66-73.U@&&1C@^U3445)0E<_?>+]#L+IK::]W
M3)]]8HVDV_7 .*=XOOI=-\+:A=0,5E5 JL.JEB%S^M6M%TBUT;3X[6V11A1O
M?',C=V)[TTDE=B?9$ECJ^GZC9FZM+N*6!<[G!QM^N>GXUE-XZ\.K,4-_D X,
MBQ.4!_WL8K%\3:) WB;2XH6:"#5',=Y%&=JRA,,,X[]1FNVCM+>*V%M'!&L
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M],TR7SII1]V68?=5?7'6K</_ "4NY_[!:?\ HPU6RLR0_M7Q7_T+4'_@<O\
MA5623Q-K<4EEY%GIL1^2>5;CSI%'< #H<'O78UR5_GP]XJBU$<:?J1$%UZ)*
M/N/^/0T1=]D#1H7UC!IO@Z\LK8;88;*15]?N'D_SK/TZ[UBW\-:,-,TR*[0V
M<>]GN!'M.T<8Q6WKW_(NZG_UZ2_^@&H_#'_(KZ5_UZ1_^@BA/W;ON'4S_P"U
M/%?_ $+MM_X'#_"MVSDN)+2)[J%89V7+QJ^X*?3/>K-%2W?H,6BBB@84444
M%%%% !1110 4444 %%%% !1110 QE5CM901Z$4U55?NHH^@HHH DI:** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M.U9VHZ99ZM;"UO85EB9<X/4'U!Z@T44+<3/-_$.H:IX3N3:Z=JUVT(/RK<%9
M-H]!E>E8O_">^)O^@F?^_,?_ ,31172DK&1Z'K[-?^ H))R2T_V9I".,DNF:
MZY/NCZ445A+8T6XZBBBI*.9T9%3QAXDV]&-N2.V?+IWA% D6L8S_ ,A2?K]1
M116DMG\B4=)111691S'CB(2>&G(9D:.9&5EQD$'CK7'_ -L:U_T&;O\ */\
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7XG?2;)GN9V9H$)8OR3M%%%8QV-&?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
